Aclarion, Inc.
Company Information
Industry
Services-Medical Laboratories
SIC Code
8071
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
8181 ARISTA PLACE, BROOMFIELD, CO, 80021
Mailing Address
8181 ARISTA PLACE, BROOMFIELD, CO, 80021
Phone
833 275 2266
Fiscal Year End
1231
EIN
473324725
Financial Overview
FY2025
$1.15M
Total Liabilities
$12.84M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 10-K Annual financial report | March 18, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 8-K Current report of material events | January 9, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | December 1, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 14, 2025 | View on SEC |
| 424B5 Prospectus supplement | October 14, 2025 | View on SEC |
Annual Reports
10-K
March 18, 2026
- Aclarion achieved a significant 50% revenue increase to $1.2 million in 2025, indicating early market traction for its diagnostic platform.
- The company successfully completed enrollment for a pivotal clinical trial for its flagship diagnostic product, with preliminary data expected in late 2026.
Material Events
8-K
Strategy Change
March 19, 2026
High Impact
- Protects existing shareholders from hostile takeovers, ensuring a fair price for the company.
- Strengthens the Board's position in negotiations, allowing them to secure the best deal for all shareholders.
Related Companies
Companies in the same industry (SIC: 8071)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.